CHAPTER 1. INTRODUCTION

• 1.1. RESEARCH METHODOLOGY
  • 1.1.1. ERC desk research
  • 1.1.2. ERC data synthesis
  • 1.1.3. Data validation and market feedback
  • 1.1.4. ERC data sources

CHAPTER 2. ANTICOAGULANTS MARKET OVERVIEW

• 2.1. ANTICOAGULANTS MARKET INTRODUCTION
• 2.2. GLOBAL ANTICOAGULANTS MARKET PRODUCTION AND GROWTH RATE, 2017-2025
  • 2.2.1. Global Anticoagulants Production (VOLUME) and Growth Rate (%), (2017-2025)
• 2.3. GLOBAL ANTICOAGULANTS MARKET CAPACITY AND GROWTH RATE, 2017-2025
  • 2.3.1. Global Anticoagulants Capacity (VOLUME) and Growth Rate (%), (2017-2025)
• 2.4. GLOBAL ANTICOAGULANTS MARKET REVENUE AND GROWTH RATE, 2017-2025
  • 2.4.1. Global Anticoagulants Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
• 2.5. GLOBAL ANTICOAGULANTS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
  • 2.5.1. Global Anticoagulants Consumption (VOLUME) and Growth Rate (%), (2017-2025)
• 2.6. GLOBAL ANTICOAGULANTS MARKET PRICE TREND, 2017-2025
  • 2.6.1. Global Anticoagulants Market Price Trend and Growth Rate (%), (2017-2025)

CHAPTER 3. GLOBAL ANTICOAGULANTS MARKET BY ADMINISTRATION TYPE, 2017-2025

• 3.1. ORAL
• 3.2. INJECTABLE
• 3.3. GLOBAL ANTICOAGULANTS MARKET REVENUE BY ADMINISTRATION TYPE, 2017-2025
  • 3.3.1. Global Anticoagulants Market Revenue (Million USD) and Share (%) By Administration type, 2017-2025
  • 3.3.2. Oral Market Revenue and Growth Rate, 2017-2025
  • 3.3.3. Injectable Market Revenue and Growth Rate, 2017-2025
• 3.4. GLOBAL ANTICOAGULANTS MARKET PRODUCTION BY ADMINISTRATION TYPE, 2017-2025
  • 3.4.1. Global Anticoagulants Market Production (Volume) and Share (%) By Administration type, 2017-2025
  • 3.4.2. Oral Market Production and Growth Rate, 2017-2025
  • 3.4.3. Injectable Market Production and Growth Rate, 2017-2025

CHAPTER 4. GLOBAL ANTICOAGULANTS MARKET BY DRUG TYPE, 2017-2025

• 4.1. FACTOR XA INHIBITORS
• 4.2. DTIS
• 4.3. VITAMIN K ANTAGONISTS
• 4.4. GLOBAL ANTICOAGULANTS MARKET REVENUE BY DRUG TYPE, 2017-2025
  • 4.4.1. Global Anticoagulants Market Revenue (Million USD) and Share (%) By Drug Type, 2017-2025
  • 4.4.2. Factor Xa inhibitors Market Revenue and Growth Rate, 2017-2025
  • 4.4.3. DTIs Market Revenue and Growth Rate, 2017-2025
  • 4.4.4. Vitamin K Antagonists Market Revenue and Growth Rate, 2017-2025
• 4.5. GLOBAL ANTICOAGULANTS MARKET CONSUMPTION BY DRUG TYPE, 2017-2025
  • 4.5.1. Global Anticoagulants Market Consumption (Volume) and share (%) By Drug Type, 2017-2025
  • 4.5.2. Factor Xa inhibitors Market Consumption and Growth Rate, 2017-2025
  • 4.5.3. DTIs Market Consumption and Growth Rate, 2017-2025
  • 4.5.4. Vitamin K Antagonists Market Consumption and Growth Rate, 2017-2025

Note: Similar information coverage has been provided for other drug type segment.

CHAPTER 5. GLOBAL ANTICOAGULANTS MARKET BY REGION, 2017-2025

• 5.1. NORTH AMERICA
  • 5.1.1. U.S.
  • 5.1.2. Canada
  • 5.1.3. Mexico
• 5.2. EUROPE
  • 5.2.1. U.K.
  • 5.2.2. France
  • 5.2.3. Germany
  • 5.2.4. Italy
  • 5.2.5. Spain
  • 5.2.6. Rest of Europe
• 5.3. ASIA PACIFIC
  • 5.3.1. China
  • 5.3.2. Japan
  • 5.3.3. India
  • 5.3.4. Korea
  • 5.3.5. Rest of APAC
• 5.4. SOUTH AMERICA
  • 5.4.1. Brazil
  • 5.4.2. Rest of South America
• 5.5. REST OF THE WORLD
  • 5.5.1. Middle East
  • 5.5.2. Africa
• 5.6. GLOBAL ANTICOAGULANTS MARKET REVENUE BY REGION, 2017-2025
  • 5.6.1. Global Anticoagulants Market Revenue (Million USD) and Share (%) By Region, 2017-2025
  • 5.6.2. North America Market Revenue and Growth Rate, 2017-2025
  • 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
  • 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
  • 5.6.5. South America Market Revenue and Growth Rate, 2017-2025
  • 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

CHAPTER 6. GLOBAL ANTICOAGULANTS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025

• 6.1. GLOBAL ANTICOAGULANTS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
  • 6.1.1. Global Anticoagulants Market Production (Volume) and Share (%) By Region, 2017-2025
  • 6.1.2. Global Anticoagulants Market Consumption (Volume) and Share (%) By Region, 2017-2025
  • 6.1.3. North America Market Production and Consumption, 2017-2025
  • 6.1.4. Europe Market Production and Consumption, 2017-2025
  • 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
  • 6.1.6. South America Market Production and Consumption, 2017-2025
  • 6.1.7. Rest of the World Market Production and Consumption, 2017-2025

CHAPTER 7. MARKET DETERMINANTS

• 7.1. MARKET DRIVERS
• 7.2. MARKET RESTRAINTS
• 7.3. MARKET OPPORTUNITIES
• 7.4. MARKET DETERMINANTS RADAR CHART

CHAPTER 8. GLOBAL ANTICOAGULANTS MARKET COMPETITION BY MANUFACTURERS

• 8.1. GLOBAL ANTICOAGULANTS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
  • 8.1.1. Global Anticoagulants Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
• 8.2. GLOBAL ANTICOAGULANTS REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
  • 8.2.1. Global Anticoagulants Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
• 8.3. ANTICOAGULANTS MARKET COMPETITIVE SITUATION AND TRENDS
  • 8.3.1. Anticoagulants Market Share (%) of Top 3 Manufacturers
  • 8.3.2. Anticoagulants Market Share (%) of Top 5 Manufacturers

CHAPTER 9. GLOBAL ANTICOAGULANTS MANUFACTURERS ANALYSIS

• 9.1. BAYER HEALTHCARE
  • 9.1.1. Business Overview
  • 9.1.2. Company Basic Information
  • 9.1.3. Anticoagulants Product Details
  • 9.1.4. Bayer HealthCare Anticoagulants Production, Revenue and Gross Margin
• 9.2. BOEHRINGER INGELHEIM
  • 9.2.1. Business Overview
  • 9.2.2. Company Basic Information
  • 9.2.3. Anticoagulants Product Details
  • 9.2.4. Boehringer Ingelheim Anticoagulants Production, Revenue and Gross Margin
• 9.3. BRISTOL-MYERS SQUIBB
  • 9.3.1. Business Overview
  • 9.3.2. Company Basic Information
  • 9.3.3. Anticoagulants Product Details
  • 9.3.4. Bristol-Myers Squibb Anticoagulants Production, Revenue and Gross Margin
• 9.4. DAIICHI SANKYO
  • 9.4.1. Business Overview
  • 9.4.2. Company Basic Information
  • 9.4.3. Anticoagulants Product Details
  • 9.4.4. Daiichi Sankyo Anticoagulants Production, Revenue and Gross Margin
• 9.5. JOHNSON & JOHNSON
  • 9.5.1. Business Overview
  • 9.5.2. Company Basic Information
  • 9.5.3. Anticoagulants Product Details
  • 9.5.4. Johnson & Johnson Anticoagulants Production, Revenue and Gross Margin
• 9.6. SANOFI
  • 9.6.1. Business Overview
  • 9.6.2. Company Basic Information
  • 9.6.3. Anticoagulants Product Details
  • 9.6.4. Sanofi Anticoagulants Production, Revenue and Gross Margin
• 9.7. ABBOTT LABORATORIES
  • 9.7.1. Business Overview
  • 9.7.2. Company Basic Information
  • 9.7.3. Anticoagulants Product Details
  • 9.7.4. Abbott Laboratories Anticoagulants Production, Revenue and Gross Margin
• 9.8. ASTRAZENECA PLC
  • 9.8.1. Business Overview
  • 9.8.2. Company Basic Information
  • 9.8.3. Anticoagulants Product Details
  • 9.8.4. Astrazeneca plc Anticoagulants Production, Revenue and Gross Margin
• 9.9. MERCK & CO., INC.
  • 9.9.1. Business Overview
  • 9.9.2. Company Basic Information
  • 9.9.3. Anticoagulants Product Details
  • 9.9.4. Merck & Co., Inc. Anticoagulants Production, Revenue and Gross Margin
• 9.10. GENENTECH INC.
  • 9.10.1. Business Overview
  • 9.10.2. Company Basic Information
  • 9.10.3. Anticoagulants Product Details
  • 9.10.4. Genentech Inc. Anticoagulants Production, Revenue and Gross Margin

CHAPTER 10. ANTICOAGULANTS MARKET VALUE CHAIN ANALYSIS

• 10.1. ANTICOAGULANTS INDUSTRIAL CHAIN ANALYSIS
• 10.2. ANTICOAGULANTS KEY RAW MATERIALS ANALYSIS
  • 10.2.1. Key Raw Materials
  • 10.2.2. Price Trend of Key Raw Materials
  • 10.2.3. Key Suppliers of Raw Materials
• 10.3. MARKETING CHANNEL
  • 10.3.1. Direct Marketing
  • 10.3.2. Indirect Marketing
  • 10.3.3. Distributors/Traders
• 10.4. CONSUMER ANALYSIS
  • 10.4.1. Consumer 1
  • 10.4.2. Consumer 2
  • 10.4.3. Consumer 3

The research report offers a comprehensive picture of the Anticoagulants market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market.

About Anticoagulants Market

Anticoagulants, are the chemical substances, which are used as a blood thinner, in order to curb the occurrence or increase of unwanted blood clots. These anticoagulants restricts the secretion of Vitamin K enzymes, typically called as vitamin K epoxide reductase which causes the clotting of blood. Anticoagulants have emerged out to be the most efficient medication therapy for the patients suffering with venous embolism, prosthetic heart valves, atrial fibrillation, and acute myocardial infarction. A major factor which is attracting the patients towards these drugs is that they have emerged out as the best alternative to the surgical AF treatment. In addition to this, rapidly growing obesity among youth and mid-aged population is also a major cause of cardiac disorders.

The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Anticoagulants report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026.

The Anticoagulants market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Anticoagulants report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porter’s Five Forces, and others are considered by the analysts while preparing the report.

Scope and Segmentation of the Market

Based on Type

By Administration Type

Oral
Injectable

Based on Application

Application 1
Application 2

Each segment of the Anticoagulants market is extensively evaluated in the research study. The segment analysis covered in the report aims at the key opportunities available in the Anticoagulants market report by leading segments. In addition, the research report offers market dynamics for the market that influences qualitative as well as quantitative research.

Research Methodology

The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provide estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. In addition, the research methodology we follow is a systematic approach in order to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.

Competitive Landscape

Key players profiled in this report include (Sales Revenue, Price, Gross Margin, Main Products, etc.):

Bayer HealthCare
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Johnson & Johnson
Sanofi
Abbott Laboratories
Astrazeneca plc
Merck & Co.
Inc.
Genentech Inc.
GlaxoSmithKline plc
Pfizer
Inc.
Novartis AG.

Through the successive chapters on the company, profiles provide deep insights on players operating in the Anticoagulants market. It focuses on the financial outlook of the key players, the status of R&D, strategies adopted, expansion strategies, and many more. Analysts preparing the report have offered a detailed list of the strategic initiatives adopted by the Anticoagulants market participants by referring past records and designing strategies to be adopted in the coming years. This enables the key players to stay ahead in the competition.

Regional Landscape

The chapter on regional segmentation details the regional aspects of the Anticoagulants market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Anticoagulants market. Moreover, the report focuses on value and volume at the regional level, company level, and level.

Chapters covered under this report include:

Chapter 1, describes the Anticoagulants market reports - market overview, executive summary, and market scope. Further, the report adds a support base to identify the information and pick in relation to the aforementioned market

Chapter 2, defines the research methodology based on primary as well as secondary research, secondary data sources, and assumptions & exclusions

Chapter 3, description of Anticoagulants market in terms of its product scope, opportunities, drivers, restraints, and market risks

Chapter 4, the report offers a company profile of the top manufacturers of Anticoagulants market with its sales, revenue, share, and others

Chapter 5 and 6, to narrow down the sales data at the country level with shares, revenue, sand sales from 2018-2026

Chapter 7, the Anticoagulants market data is published based on a regional level and to show the revenue, sales, and growth on basis of the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026

Chapter 8, describes the Anticoagulants market sales channels, distributors, research findings, appendix, and among others.